Form4insider filings, from the source

SEC Form 4 · accession 0001055726-18-000008

INOVIO PHARMACEUTICALS, INC. · INO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jong Joseph Kim
Officer — Chief Executive Officer · Director
Period of report
Mar 9, 2018
Accepted (ET)
Mar 13, 2018 · 6:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 9, 2018M57,333—A2,232,155D
Common StockMar 9, 2018F15,944$4.51D2,216,211D
Common StockF3Mar 10, 2018M105,700—A2,321,911D
Common StockMar 10, 2018F30,104$4.51D2,291,807D
Common Stockholding———1,750,000IBy Family Limited Partnership
Common Stockholding———33,563IBy Daughter: EK
Common Stockholding———33,775IBy Son: JK1
Common Stockholding———5,975IBy Spouse
Common Stockholding———33,533IBy Son: JK2

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF1—Mar 9, 2018M57,334D——Common Stock57,33357,333D
Restricted Stock UnitF3—Mar 10, 2018M105,700D——Common Stock105,700211,400D

Explanation of responses